OI
CVS icon

Oakbrook Investments’s CVS Health CVS Stock Holding History

Oakbrook Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$209K Sell
3,528
-12,090
-77% -$807K 0.53% 74
2019
Q4 		$1.16M Sell
15,618
-50,796
-76% -$3.57M 0.24% 90
2019
Q3 		$4.19M Sell
66,414
-10,411
-14% -$617K 0.27% 56
2019
Q2 		$4.19M Buy
76,825
+1,243
+2% +$66.9K 0.25% 69
2019
Q1 		$4.08M Buy
75,582
+29,920
+66% +$1.85M 0.25% 68
2018
Q4 		$2.99M Buy
45,662
+6,557
+17% +$489K 0.2% 84
2018
Q3 		$3.08M Hold
39,105
– – 0.17% 97
2018
Q2 		$2.52M Buy
39,105
+440
+1% +$29K 0.16% 103
2018
Q1 		$2.4M Buy
38,665
+2,050
+6% +$147K 0.15% 112
2017
Q4 		$2.65M Buy
36,615
+29,244
+397% +$2.13M 0.17% 92
2017
Q3 		$599K Buy
7,371
+2,500
+51% +$198K 0.04% 303
2017
Q2 		$392K Sell
4,871
-950
-16% -$75K 0.03% 369
2017
Q1 		$457K Sell
5,821
-51,175
-90% -$4.09M 0.03% 356
2016
Q4 		$4.5M Sell
56,996
-52,550
-48% -$4.25M 0.29% 67
2016
Q3 		$9.75M Sell
109,546
-5,650
-5% -$533K 0.6% 42
2016
Q2 		$11M Buy
115,196
+51,650
+81% +$5.15M 0.61% 41
2016
Q1 		$6.59M Buy
63,546
+42,925
+208% +$4.17M 0.42% 56
2015
Q4 		$2.02M Sell
20,621
-47,350
-70% -$4.64M 0.13% 141
2015
Q3 		$6.56M Sell
67,971
-28,550
-30% -$3M 0.43% 56
2015
Q2 		$10.1M Buy
96,521
+71,050
+279% +$7.26M 0.62% 41
2015
Q1 		$2.63M Sell
25,471
-4,875
-16% -$493K 0.14% 156
2014
Q4 		$2.92M Sell
30,346
-62,350
-67% -$5.49M 0.16% 133
2014
Q3 		$7.38M Sell
92,696
-229,440
-71% -$18.1M 0.4% 62
2014
Q2 		$24.3M Buy
322,136
+25,100
+8% +$1.9M 0.73% 32
2014
Q1 		$22.2M Sell
297,036
-104,236
-26% -$7.36M 0.7% 38
2013
Q4 		$28.7M Sell
401,272
-37,425
-9% -$2.4M 0.8% 32
2013
Q3 		$24.9M Buy
438,697
+178,561
+69% +$10.6M 0.73% 38
2013
Q2 		$14.9M Buy
+260,136
New +$15.1M 0.43% 58

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oakbrook Investments's CVS Position: Q1 2020 in Review

Oakbrook Investments reduced its CVS Health (CVS) stake by 77% in Q1 2020, selling an estimated $807K and leaving 3,528 shares worth $209K. The position accounts for 0.53% of the portfolio, ranked #74.

Oakbrook Investments first reported a position in CVS in Q2 2013 and has held it in 28 quarters since. The position peaked at $28.7M in Q4 2013. 1,816 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

  • Oakbrook Investments held 3,528 shares of CVS Health worth $209K as of Q1 2020.
  • Oakbrook Investments sold 12,090 CVS Health shares in Q1 2020, an estimated $807K.
  • CVS Health made up 0.53% of Oakbrook Investments's portfolio in Q1 2020, its #74 holding.
  • Oakbrook Investments first reported a position in CVS Health in Q2 2013 and has held it in 28 quarters since.
  • Oakbrook Investments's CVS Health position peaked at $28.7M in Q4 2013.
  • 1,816 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.